1.4900
+0.0500
+(3.47%)
At close: 5:33:21 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in BRL | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 9 | 9 |
Avg. Estimate | 8.36B | 9.39B | 35.72B | 36.16B |
Low Estimate | 7.78B | 9.05B | 32.15B | 31.92B |
High Estimate | 8.94B | 9.72B | 38.89B | 41.83B |
Year Ago Sales | 9.06B | 9.44B | 39.82B | 35.72B |
Sales Growth (year/est) | -7.72% | -0.51% | -10.29% | 1.24% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CID.F | -- | -- | -- | -- |
S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
Downgrade | B of A Securities: Buy to Neutral | 11/24/2023 |
Upgrade | HSBC: Hold to Buy | 11/1/2023 |
Upgrade | B of A Securities: Neutral to Buy | 9/20/2023 |
Downgrade | JP Morgan: Overweight to Neutral | 4/4/2018 |
Upgrade | JP Morgan: Neutral to Overweight | 11/27/2017 |
Downgrade | Goldman Sachs: Neutral to Sell | 7/14/2017 |